J L Gottschall
Overview
Explore the profile of J L Gottschall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gehrie E, Roubinian N, Chowdhury D, Brambilla D, Murphy E, Gottschall J, et al.
Vox Sang
. 2017 Dec;
113(2):160-169.
PMID: 29277907
Background And Objectives: Many hospitals require transfusions to be discontinued when vital signs stray from predetermined ranges, regardless of clinical symptoms. Variations in vital signs may be unrelated to transfusion,...
2.
Cancelas J, Gottschall J, Rugg N, Graminske S, Schott M, North A, et al.
Vox Sang
. 2017 Feb;
112(3):210-218.
PMID: 28220519
Background And Objectives: Pathogen reduction technology using amustaline (S-303) was developed to reduce the risk of transfusion-transmitted infection and adverse effects of residual leucocytes. In this study, the viability of...
3.
Roubinian N, Hendrickson J, Triulzi D, Gottschall J, Chowdhury D, Kor D, et al.
Vox Sang
. 2016 Dec;
112(1):56-63.
PMID: 28001313
Background: The concordance of haemovigilance criteria developed for surveillance of transfusion-associated circulatory overload (TACO) with its clinical diagnosis has not been assessed. In a pilot study to evaluate an electronic...
4.
Devine D, Sher G, Reesink H, Panzer S, Hetzel P, Wong J, et al.
Vox Sang
. 2010 May;
98(3 Pt 1):e295-363.
PMID: 20432515
A critical aspect of blood transfusion is the timely provision of high quality blood products. This task remains a significant challenge for many blood services and blood systems reflecting the...
5.
JENKINS C, Johnson S, Bellissimo D, Gottschall J
Immunohematology
. 2006 Feb;
21(4):152-4.
PMID: 16472016
The incidence of weak D has been reported to be between 0.23 and 0.5 percent in Europe and 3.0 percent in the United States. All studies were performed before the...
6.
Wohlfeil E, Woehlck H, Gottschall J, Poole W
Anesth Analg
. 2001 May;
92(6):1609-10.
PMID: 11375855
No abstract available.
7.
Raife T, Atkinson B, Aster R, McFarland J, Gottschall J
Am J Hematol
. 1999 Oct;
62(2):82-7.
PMID: 10509001
Thrombotic thrombocytopenic purpura (TTP) is a syndrome characterized by microvascular thrombosis with thrombocytopenia and end-organ injury. Evidence suggests that platelet or endothelial cell injury may be initial pathological events in...
8.
Sarode R, Gottschall J, Aster R, McFarland J
Am J Hematol
. 1997 Feb;
54(2):102-7.
PMID: 9034283
Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the...
9.
Drobyski W, Potluri J, Sauer D, Gottschall J
Bone Marrow Transplant
. 1996 Jun;
17(6):1093-9.
PMID: 8807120
The development of immune-mediated hemolytic anemia is a well-recognized complication after allogeneic bone marrow transplantation (BMT). The majority of reported cases, however, have been alloimmune in origin due to ABO...
10.
Gottschall J, Neahring B, McFarland J, Wu G, Weitekamp L, Aster R
Am J Hematol
. 1994 Dec;
47(4):283-9.
PMID: 7977300
Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome (HUS) is a recently defined clinical entity. In this paper we have attempted to characterize the natural history and laboratory abnormalities typical of...